Breaking News - The Fly

Open Search

EXEL

Exelixis

$

()

Exelixis just downgraded at Barclays, here's why

EXEL

4/11/2024 - 04:42am

Biotech Alert: Searches spiking for these stocks today

TCON , EXEL

3/11/2024 - 11:13am

Exelixis exec Haley sells 47,020 common shares

EXEL

2/27/2024 - 19:01pm

Fly Insider: Exelixis, Akami among week's notable insider trades

ADC , EXEL , HRTG

…

2/26/2024 - 15:11pm

Biotech Alert: Searches spiking for these stocks today

ADXS , TENX , NVIV

…

2/9/2024 - 11:12am

Exelixis backs FY24 revenue view $1.825B-$1.925B, consensus $1.91B

EXEL

2/6/2024 - 16:18pm

Exelixis reports Q4 adjusted EPS 33c, consensus 21c

EXEL

2/6/2024 - 16:17pm

Cybrexa regains rights to CBX-12

EXEL

2/6/2024 - 08:12am

Exelixis price target raised by $1 at Barclays, here's why

EXEL

1/30/2024 - 05:26am

Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

EXEL , MRK , ESSA

…

1/29/2024 - 11:50am

Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

EXEL , MRK , ESSA

…

1/29/2024 - 04:55am

Exelixis announces results of study evaluating cabozantinib in mCRPC treatment

EXEL

1/25/2024 - 08:10am

Cantor Fitzgerald biotech analysts hold an analyst/industry conference call

EXEL , MRK , ESSA

…

1/24/2024 - 16:47pm

Bristol Myers, Exelixis announce four-year results from Opdivo-Cabometyx trial

BMY , EXEL

1/22/2024 - 17:03pm

EPO rules in favor of Exelixis on patent covering Cabometyx

EXEL , TEVA

1/18/2024 - 16:08pm